13 new recruits start their orientation within a carefully tailored training program around 57357’s values and culture
It was about time to have our own 57357 pediatric oncology residency program. Armed with our polished experience in the 57357 training academy based joint 57357/ Dana Farber Boston Children’s fellowship program, a team headed by Dr. Emad Moussa put together the road map and curriculum of the residency program. The main goal of the 3 year program is to offer our residents a well-structured and planned quality training which would not only give them expertise in the field of pediatric oncology but also train them around the core principles and values and of 57357’s vision, mission and aspirations.
Another pursuit of the residency program is to start the process of transformative learning with the new recruits, one that would ultimately lead them to becoming change agents capable of ushering in change and progress in Egypt’s healthcare field. Yesterday the trainees were given besides their orientation tour within the premises a comprehensive presentation about 57357’s cancer awareness program.
The thirteen recruits were chosen according to a well-thought selection process. Trainees must have their medical degree in Pediatrics and one year practicing experience in university or armed forces Hospitals. Their performance is evaluated every three months. The Residency program is another milestone on the road of meeting the increased demand for pediatric oncologists in Egypt and the surrounding region.
Residency is a phase of medical training for graduate physicians. Medical residency gives in-depth training within a specific branch of medicine. A resident is a doctor who practices medicine typically under the supervision of an attending physician. To obtain an unrestricted license to practice medicine in many territories, it is required to successfully complete a residency program. Residency training may be followed by a fellowship or a “sub-specialty” training.